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Key message  
This paper describes the secure real-time integration of electronic patient reported adverse 
event (AE) data into the electronic patient record system (EPR) in a leading UK Cancer 
Centre. eRAPID (electronic patient self-Reporting of Adverse-events): Patient Information 
and aDvice) allows AE reporting from home and generates self-management advice for low 
or moderate AE and for severe AE immediate advice to contact the hospital. Clinicians view 
patient AE data in the EPR and receive email notification of severe AE.   
Abstract  
Background  
Significant adverse events (AE) during cancer therapy disrupt treatment and escalate to 
emergency admissions. Approaches to improve the timeliness and accuracy of AE reporting 
may improve safety and reduce health service costs.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
Reporting AE via Patient Reported Outcomes (PROs), can improve clinician-patient 
communication and making data available to clinicians in ‘real time’ using electronic PROs 
(ePROs) could potentially transform clinical practice by providing easily-accessible records 
to guide treatment decisions. This manuscript describes the development of eRAPID 
(electronic patient self-Reporting of Adverse-events: Patient Information and aDvice) is a 
National Institute for Health Research (NIHR) funded programme,a system for patients to 
self-report and manage AE online during and after cancer treatment.  
 
2 
 
Materials and methods 
A multi-disciplinary team of IT experts, staff and patients developed using agile principles a 
secure web application interface (QStore) between an existing online questionnaire builder 
(QTool) displaying real-time ePRO data to clinicians in the electronic patient record (EPR) at 
Leeds Teaching Hospitals NHS Trust (LTHT). Hierarchical algorithms were developed 
corresponding to Common Terminology Criteria for Adverse Events (CTCAE) grading using 
the QTool question dependency function. Patient advocates (N=9), patients (N=13) and staff 
(N=19) usability tested the system reporting combinations of AE.  
Results 
The eRAPID system allows patients to report AE from home on PC, tablet or any web 
enabled device securely during treatment. The system generates immediate self-
management advice for low or moderate AE and for severe AE advice to contact the hospital 
immediately. Clinicians can view patient AE data in the EPR and receive email notifications 
when patients report severe AE.  
Conclusions 
Evaluation of the system in a Randomised Controlled Trial in breast, gynaecological and 
colorectal cancer patients undergoing systemic therapy is currently underway. To adapt  
eRAPID for different treatment groups pilot studies are being undertaken with patients 
receiving pelvic radiotherapy and upper gastrointestinal surgery. 
Clinical trials numbers ISCTRN CCT-NAPN-21338 and ISRCTN88520246.  
Key words: Cancer Adverse Events; Patient Reported Outcome Measures(PROMs); Electronic Patient Reported 
Outcomes (ePROs), Electronic Patient Records (EPR); Internet Intervention: Self-management 
 
Introduction  
Significant adverse events (AE) during cancer therapy can disrupt treatment and impair 
quality of life (QOL) [1, 2]. In the UK The National Confidential Enquiry Report into Patient 
Outcome and Death (NCEPOD) highlighted increased emergency department admissions 
and limited support for patients experiencing chemotherapy-related AE [1]. An audit of the 
acute oncology service in Leeds Hospitals NHS Trust (LTHT) found patients often delay 
reporting even severe symptoms [3].  Approaches to improve care and avoid preventable 
emergency admissions may contribute to improving cancer patients’ safety and QOL and 
reduce health costs.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
Reporting symptoms and side effects via Patient Reported Outcomes (PROs), can improve 
clinician-patient communication and the accuracy of clinician-reported AE [4-6]. The last 20 
years has seen an increase in electronic PRO systems [7] providing timely and effective 
solutions to capture and utilise PRO data in a range of clinical contexts [7, 8].   
Patients can report QOL and chemotherapy AE via PROs in clinical practice using home 
internet [9] or mobile phones (ASyMS) [10]. Successful implementation of electronic PRO 
systems include: PatientViewpoint, [11], the Computer-based Health Evaluation Software 
(CHES) [12], and the Symptom Tracking and Reporting System (STAR) for PRO AE 
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reporting during chemotherapy [13]. To support online reporting patient education is also 
recommended [14] along with an ethical responsibility to provide patients with clear guidance 
on managing severe AE and alerting their clinical team [15]. 
Making data available to clinicians in ‘real time’ using electronic PRO (ePRO) could have the 
most transformative effect on clinical practice by providing easily-accessible records to guide 
treatment decisions [16]. The increased use of Electronic Patient Records (EPRs) and 
patient access to health records has created opportunities for the integration of PRO 
systems with clinical data.  
A challenge of linkage to an internet based ePRO system is to maintain the security of 
sensitive patient data in the EPR. In the UK NHS, the single secure N3 network connects all 
NHS organisations [17].  Approved third parties (e.g. prescribing systems) access to the 
NHS is subject to strict governance.  
Previously, in Leeds Cancer Centre a highly scalable electronic online questionnaire 
management software QTool was developed by X-lab (a private software company) for 
ePRO data collection. QTool facilitates building and scheduling of flexible questionnaires to 
match clinical needs.  When complete, the PRO data is instantly accessible and 
downloadable for analysis. QTool was used in a study of 600 cancer survivors [18] 
successfully linking group PRO data to the cancer registry. However, PRO responses were 
not integrated into the EPR. 
The Leeds Cancer Centre EPR (PPM-Patient Pathway Manager) is used in NHS trusts 
across the Yorkshire region [19] to coordinate the care of over 2 million patients. PPM has 
an integrated clinical trials module enabling allocation of patients to research studies, 
management of trial documents and correlation of demographic and clinical information with 
trial data.   
Building on these platforms we initiated the National Institute for Health Research (NIHR) 
funded eRAPID programme (electronic patient self-Reporting of Adverse-events: Patient 
Information and aDvice) [20]. eRAPID aimed to design and evaluate a system for patients to 
self-report and manage AE during and after cancer treatment. To support the programme we 
developed an innovative, secure interface between the QTool system and the existing Leeds 
Cancer Centre EPR known as Patient Pathway Manager (PPM).  
The aims of this project were to develop:  
1. Secure real-time integration of the online questionnaire system (QTool) with the EPR in 
Leeds Cancer Centre (within N3 network restrictions) including a user-friendly and easily-
accessible display of PRO data for clinicians. 
2. Clinically-based algorithms providing patients with immediate, automated tailored advice 
on managing AE, and notification via email for severe AE to clinicians.  
3. Improved usability and functionality of the QTool patient interface to support patients to 
login securely and easily report and manage AE from web enabled devices  
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Theoretical foundations and rationale for approach of the eRAPID system 
Following recommended Criteria for Reporting the Development and Evaluation of Complex 
Interventions in Healthcare [21] we have described the theoretical underpinnings of eRAPID 
and the aims, essential functions and rationale for selection of the individual components 
(S1).  
Methodological approach and procedures  
A Multi-disciplinary project team (MDPT) led the development which included researchers, 
lead oncology clinicians, health informatics professionals (X-Lab), a patient advocate group 
and lay members from the National Cancer Research Institute (NCRI) patient and public 
involvement group. Key roles included a technical lead working within a disciplined agile 
framework [22] to enhance the software to fit stakeholder specifications. A researcher in a 
liaison role translated the research and clinical needs to the IT team and led system usability 
testing.  
A wider stakeholder group of clinical staff (N=19), Patient advocates (N=9) and patients 
(N=13) administrators and researchers was continuously consulted throughout to: 1) elicit 
initially the requirements of the system; 2) validate the content and design by reviewing each 
iteration of the eRAPID platform.  This was achieved either via direct interviews, meetings 
participation or, telephone contacts. Responses were charted thematically [23] and if 
required changes made to the next iteration.  
An overview of the work in chronological order is provided in Figure 1. Below, we report the 
methods and results for each aim. 
Insert Figure 1 
1. Secure real-time integration of the online questionnaire system (QTool) with the EPR 
including a user-friendly and easily-accessible display of PRO data for clinicians. 
Method  
Stakeholder requirements were elicited via interviews and summarised to inform the 
technical specifications (S2). A key challenge when integrating PRO data into the EPR was 
to develop a scalable way to display PRO results to clinicians whilst maintaining the security 
of patient data. QStore, a web application, was developed (hosted within the NHS network) 
to access the QTool secure anonymised interface and retrieve and store PRO data utilising 
the existing clinical trials module in PPM. QStore was developed using ASP.NET MVC and 
SQL Server. Using Task Scheduler, a .NET windows application retrieves and stores PRO 
data from QTool every 5 minutes. 
Results 
The resulting data flow through the system is illustrated in Figure 2 with descriptions of how 
the system meets the needs of the key stakeholders. Identifiable and sensitive patient data 
is held securely in the EPR database behind the NHS firewall. QStore links each patient 
EPR record to QTool and allocates a unique QTool login name. 
Insert figure 2   
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Patients are given a postcard with their login details which allows access to eRAPID via the 
website portal (Figure 3) from home, hospital kiosks or any web-enabled device. On 
completion of the AE items patients can view their own data (over time) in tabular or 
graphical formats, and may receive severity-dependent advice (see aim 2). They have the 
facility to print or email the results. eRAPID generates weekly text message or email 
reminders to encourage completion. Adherence is monitored though system tracking 
(website visits and questionnaire completion) and evaluated by the number of appropriate 
contacts with the hospital, alerts and admissions. QStore pulls PRO data every few minutes 
and displays it to clinicians in tabular or graphical format with level 3 symptoms highlighted in 
red (figure 3) 
 Insert figure 3  
 2. Clinically-based algorithms providing patients with immediate, automated tailored advice 
on managing AE, and notification via email for severe AE to clinicians  
Methods. The existing question scoring dependency function in QTool was utilised to 
construct hierarchical algorithms triggering immediate severity dependent advice based on 
AE grading dependant on how the patient answers a question or combination of questions. 
The eRAPID symptom report questionnaires are patient reported AE adaptations (PRAE) 
[24] of the gold standard clinician reporting system (CTCAE version 4.0) [25]. The responses 
for each question are allocated a score from 0-3 corresponding to the CTCAE severity 
grades and the United Kingdom Oncology Nursing Society (UKONS) triage forms [26] (see 
table 1).  
Insert table 1  
Five hierarchical algorithms were developed corresponding to the UKONS severity levels 0-3 
ranging from A1 (most severe) to D (least severe) (S3). For severe symptoms triggering A1 
an email notification is automatically sent to one (or more) clinicians advising them to view 
the PRO report in the EPR. Corresponding AE advice was sourced from local and national 
guidelines accessible via QTool or a customised website [27]. Both the algorithms and 
patient advice were developed though iterative review with the stakeholder group: 19 
clinicians, 9 patient advocates and 13 patients via face-to face or telephone interview, and 
though discussion at project management meetings, see (S4) for demographic detail.  
Additionally, we asked the clinicians to complete the eRAPID symptom report questionnaire 
(from the patient perspective) following two chemotherapy-related AE scenarios (S5) [23].  
The scenarios were designed to test the algorithms to ensure relevant severity-dependent 
advice was triggered.   
Results. The clinical algorithms, implemented in QTool via the scoring system and 
dependencies, allow patients to receive immediate targeted advice for low or moderate AE 
to help self-management with links to relevant webpages for more detailed information. For 
severe AE they are advised to contact the hospital immediately (see figure 3).  
Clinicians receive an email notification for severe symptoms) detailing the patient’s QTool 
username and the symptom(s) reported. A report corresponding to the notification was 
created in the EPR identifying the patient with the QTool username, allowing the clinician to 
open the medical records and respond to the notification. The scenario-based testing of the 
algorithms did not reveal any issues. 
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3. Improved usability and functionality of the QTool patient interface 
Methods. To test the eRAPID symptom reports and algorithms we initially engaged 19 
clinicians and 9 patient advocates who reported combinations of symptoms and severities. 
Comments were collated on: logging in, accessing the system, navigation through the 
questionnaire; accessing their results and self-management advice and printing or emailing 
results.  Staff and patients responded verbally via semi structured audio-recorded interview 
and written comments.  Data were charted and analysed thematically [23].  Changes were 
made and subsequently the full eRAPID system was tested in a convenience sample of 13 
patients receiving chemotherapy using interviews and written comments for feedback for 
demographic details see (S4). 
Results. Key points from staff and patient feedback included: patient safety, accessing the 
24-hour hotline number within the QTool management advice, accessing and navigating 
through the system and patients viewing and accessing results. Significant improvements 
were to made see (S6).  
Discussion  
We have successfully developed an online system for PRO reporting of AE with an existing 
EPR in real-time whilst maintaining patient confidentiality and security and meeting the key 
stakeholder specifications.  
Patients can now report AE from home on PC, tablet or smart phone securely during 
treatment and receive appropriate management advice via the severity dependent 
algorithmic questionnaire scoring. Clinicians can view patient AE data in the EPR and 
receive email notifications when patients report severe symptoms. The immediate severity-
related guidance on how to manage AE is a unique feature of our system compared to other 
ePRO web-portals [11-13,16].  
Key security concerns were addressed though development of QStore allowing non-
identifiable questionnaire response data to be transferred through NHS firewalls. We have 
achieved this with the full support of, and in close collaboration with, the local EPR 
development team supported by LTHT thus ensuring the smooth integration of the system.  
The content and design of the system was developed with the programmer, research liaison, 
clinicians and patient advocates on the project management team and validated through 
usability testing. We developed an accessible intuitive staff, researcher and patient interface 
by identifying and troubleshooting system errors and usability issues prior to introduction to 
patients/clinicians.   
In future we will work with staff to determine the level of support needed to integrate the 
system into the care pathways of different treatment groups and provide extensive staff 
training to ensure smooth adoption of the system.  
The system is functioning within the local EPR but we have adapted eRAPID to meet the 
needs of different patient groups in UK NHS settings. Implementation work is currently 
underway in Manchester and Bristol for pelvic radiotherapy and upper gastrointestinal 
surgery respectively.  
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Collection of large scale patient reported AE data poses challenges for data capture, 
storage, security and integration into patient care pathways. We do not underestimate the 
challenges of interfacing QTool with other NHS EPR as success is dependent on local 
system limitations. QTool was developed for web browsers of computers or tablets.  
Usability could be improved by developing smartphone apps but such approach would 
reduce the flexibility of changing patient questions and increase the development cost of 
apps for different smartphone platforms  
Conclusion and Future challenges 
We have successfully developed a secure interface between an online integrated electronic 
system for PRO data collection and an EPR in a single cancer centre. A remaining challenge 
is the implementation in busy hospitals considering the administrative procedures and 
resource requirements. To assess the staff and patient training needs and the acceptability 
of the system we plan to test the full eRAPID intervention in a sample of breast cancer 
patients on adjuvant chemotherapy. This will provide an opportunity to refine the system 
prior to its full evaluation in a Randomised Controlled Trial in breast, gynaecological and 
colorectal cancer patients undergoing systemic therapy.  
Acknowledgements 
This work was completed by the Patient Reported Outcomes Group: Leeds Institute of 
Cancer Studies and Pathology, Bexley Wing, St James's Hospital, Beckett Street, Leeds, 
LS9 7TF: University of Leeds UK 
We would like to thank Colin Johnston, Robert Carter, Joe Shaw and the wider Patient 
Reported Outcomes Group for their help in developing and testing the system.   
Clinical staff  Oncologists: Geoff Hall; Daniel Swinson; Alison Young; Clive Mulatero and 
Virgil Sivoglo; Nurses: Sue Bramham-Exley; Sue Goulding; Evelyn Tatham; Alison Craven; 
Louise Taylor; Lead Cancer Nurse Krystina Koslowska; lead Chemotherapy Nurse Anne-
Marie Kenny. Dietician Bryony Clarke; Physiotherapists: Clare Parsons and Allison Gullvag; 
Clinical Psychologist Sarah Catesby and Macmillan Information Specialist Sadie Smith 
Patient advocates 
We would like to thank the POG research advisory group particularly Tony Betts and Sara 
El-Hassani, for their contribution to usability testing. Sara El-Hassani was a passionate and 
dedicated patient advocate who sadly passed away in 2015.  
Project management team 
Professors Jenny Hewison; Peter Selby; Julia Brown; Clare Hulme Jane Blazeby Norah 
Kearney and Rick Jones who sadly passed away in 2014; Doctors Lucy Ziegler; Clare 
Harley; Geoff Hall; Kevin Franks; Others: Martin Waugh and David Fox; Krystina Koslowska 
and Mrs Sue Kier who sadly passed away in 2012. 
Funding 
This paper presents independent research funded by the National Institute for Health 
Research (NIHR) under its Program Grants for Applied Research Program (Reference 
8 
 
Number RP-DG-1209-10031).The views expressed are those of the authors and not 
necessarily those of the NHS, the NIHR or the Department of Health. 
Disclosure: The authors have declared no conflicts of interest. 
 
References  
1. Mort D, Lansdown M, Smith N, Protopapa K, Mason M: For better, for worse? A review of 
the care of patients who died within 30 days of receiving systemic anti-cancer therapy. 
London: National Confidential Enquiry into Patient Outcome and Death; 2008. 
2. De Luigi A: Analysis of reasons for admission to the emergency department for cancer 
patients. Ann Oncol 2002, 13:112. 
3. Warrington L, Holch, P, Kenyon L, et al. An audit of acute oncology services: Patient 
experiences of admission procedures and staff utilisation of a new telephone triage system. 
Support Care Cancer 24(12) 5041-5048 
4. Velikova G, Booth L, Smith AB, et al.  Measuring quality of life in routine oncology practice 
improves communication and patient well-being: a randomized controlled trial. J Clin Oncol 
2004, 22:714-724. 
5. Basch E, Bennett A, Pietanza MC: Use of patient-reported outcomes to improve the 
predictive accuracy of clinician-reported adverse events. J Natl Cancer I 2011, 103:1808-
1810. 
6. Black N: Patient reported outcome measures could help transform healthcare. BMJ 2013, 
346: 167. 
7. Johansen MA, Henriksen E, Horsch A, et al. Electronic symptom reporting between 
patient and provider for improved health care service quality: a systematic review of 
randomized controlled trials. part 1: state of the art. J Med Internet Res 2012,14:e118. 
8. Jensen RE, Snyder CF: PRO-cision Medicine: Personalizing Patient Care Using Patient-
Reported Outcomes. J Clin Oncol 2016, 34:527-529. 
9.  Basch E, Artz D, Dulko D, et al. Patient Online Self-Reporting of Toxicity Symptoms 
During Chemotherapy. J Clin Oncol 2005, 23:3552-3561. 
10. McCann L, Maguire R, Miller M, Kearney N: Patients' perceptions and experiences of 
using a mobile phone-based advanced symptom management system (ASyMS) to monitor 
and manage chemotherapy related toxicity. Eur J Cancer Care 2009, 18:156-164. 
11. Snyder CF, Jensen R, Courtin SO, et al: PatientViewpoint: a website for patient-reported 
outcomes assessment. Quality of life research 2009, 18:793-800. 
12. Holzner B, Giesinger JM, Pinggera J, et al. The Computer-based Health Evaluation 
Software (CHES): a software for electronic patient-reported outcome monitoring. BMC Med 
Inform Decis Mak 2012, 12:126. 
9 
 
13.  Basch E, Deal AM, Kris MG, et al: Symptom Monitoring With Patient-Reported 
Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial. J Clin Oncol 
2016, 34:557-565. 
14. Berry DL, Hong F, Halpenny B, et all: The electronic self report assessment and 
intervention for cancer: promoting patient verbal reporting of symptom and quality of life 
issues in a randomized controlled trial. BMC cancer 2014, 14:513. 
15. Kyte D, Draper H, & Calvert M: Patient-reported outcome alerts: ethical and logistical 
considerations in clinical trials. JAMA 2013, 310:1229-1230. 
16. Holzner B, Giesinger JM, Zabernigg A, et al. Patients' preferences regarding the setting 
of electronic patient-reported outcome assessments. Val Health 2015, 18 (7):A473. 
17 Read I: N3 Network User Guide v1.3. 2010. accessed November 2016 
18. Ashley L, Jones H, Thomas J, et al.  Integrating patient reported outcomes with clinical 
cancer registry data: a feasibility study of the electronic Patient-Reported Outcomes From 
Cancer Survivors (ePOCS) system. J Med Internet Res 2013, 15:e230. 
19. Newsham AC, Johnston C, Hall G, et al.  Development of an advanced database for 
clinical trials integrated with an electronic patient record system. Comput Biol Med 2011, 
41:575-586. 
20. Absolom, K., Holch, P., Warrington, L. et al. Electronic patient self-Reporting of adverse-
events: Patient information and advice (eRAPID): A randomised controlled trial in systemic 
cancer treatment. BMC Cancer, 2017 17: 318  
21.  Möhler, R, Köpke, S & Meyer, G. Criteria for Reporting the Development and Evaluation 
of Complex Interventions in healthcare: revised guideline (CReDECI 2). Trials, 2015 16:204  
22. Ambler SW & Lines M. Disciplined agile delivery: A practitioner's guide to agile software 
delivery in the enterprise, 2012: IBM Press 
23. Rogers ML PE, Chapman R, et al. Usability Testing and the Relation of Clinical 
Information Systems to Patient Safety. In Advances in Patient Safety: From Research to 
Implementation (Volume 2: Concepts and Methodology) 2005 Henriksen K BJ, Marks ES 
(Eds) Rockville (MD): Agency For Heathcare Research and Quality (US) 
24. Holch P, Warrington L, Potrata B, et al.  Asking the right questions to get the right 
answers: using cognitive interviews to review the acceptability, comprehension and clinical 
meaningfulness of patient self-report adverse event items in oncology patients. Acta Oncol 
2016: 9-10,1220-1226. 
25. National Institutes of Health and National Cancer Institute: Common Terminology Criteria 
for Adverse Events (CTCAE) Version 4.0 2009; U.S.Department of Health and Human 
Sciences; NIH & NCI 
26. Acute Oncology Initial Management Guidelines 
http://ukons.org/contentimages/FINAL_GUIDELINE_V_1.0_11.pdf accessed September 
2011 
10 
 
27. Hector, C., Holch, P., Warrington, L et al. Development of online patient-advice for the 
self-management of low-level chemotherapy related toxicities (eRAPID): Involvement of 
patients and staff Psycho-Oncology, 2013 22: 11.  
 
Table 1: CTCAE (version 4.0) vomiting item, corresponding patient reported version and 
CTCAE and UKONS severity grading (0-3) 
 
CTCAE  
(version 4.0)  
Vomiting item 
PRAE item 
Have you been 
sick (vomited)? 
CTCAE 
Grade 
CTCAE Version 4.0 
General description of 
severity grading  
UKONS 
N/A N/A 0 N/A No problem reported 
and no advice needed. 
1 - 2 episodes 
(separated by 5 
minutes) in 24 hrs 
I have vomited 1 - 
2 times in a 24 
hour period 
1 Mild; asymptomatic or 
mild symptoms; clinical or 
diagnostic observations 
only; intervention not 
indicated. 
Mild problem not 
requiring medical 
attention, self-
management is 
appropriate. 
3 - 5 episodes 
(separated by 5 
minutes) in 24 hrs 
I have vomited 3 - 
5 times in a 24 
hour period 
2 Moderate; minimal, local 
or non-invasive 
intervention indicated; 
limiting age-appropriate 
instrumental ADL 
Potentially serious 
problem, may require 
medical attention. 
>=6 episodes 
(separated by 5 
minutes) in 24 
hrs; tube feeding, 
TPN or 
hospitalization 
indicated 
I have vomited 6 
or more times in a 
24 hour period 
3 Severe or medically 
significant but not 
immediately life-
threatening; 
hospitalization or 
prolongation of 
hospitalization indicated; 
disabling; limiting self- 
care ADL. 
Potential medical 
emergency, requires 
urgent medical review. 
ADL: activities of daily living; Instrumental ADL (preparing meals, shopping for groceries or clothes, using the telephone, 
managing money, etc.), Self-care ADL (bathing, dressing and undressing, feeding self, using the toilet, taking medications, and 
not bedridden)  
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Figure 1:  Flow chart of timelines of the development of the eRAPID system  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend: QTool online questionnaire builder; EPR: Electronic patient records; PPM: patient pathway manager; 
PRAE: Patient Reported Adverse Event Items; CTCAE: Common Terminology Adverse Events; UKONS, 
United Kingdom Oncology Nursing Society; QStore: Link between QTool and EPR; MDPT: Multidisciplinary 
Project Team.  
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Figure 2: eRAPID system diagram describing the data flow from public internet to hospital 
network 
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Figure 3: Screen shots of the Patient view: a) eRAPID website portal screen, b) QTool 
patient welcome page with links to questionnaires, previous responses and feedback, c) 
Example of the eRAPID symptom report ,d) AE Self-management advice generated from 
QTool when patient reports mild/moderate  symptoms, e) If patients report low level AE they 
are directed to the eRAPID website for self-management advice, f) if patients report a severe 
AE and if it is a current problem advice (in red) to telephone the hospital is generated, g) 
patient view of the tabular summary of AE reported, h) Patient view of the graphical 
summary of their responses. Clinician view: i) graphical display of a one-time completion of 
PRO results, j) display of PRO reported results in the EPR in tabular form with severe 
symptoms indicated in red, k) graphical display of completion over time with red triangles 
indicating chemotherapy cycles.  
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Online supplementary material (S1-6) 
S1: Theoretical underpinnings of the complex intervention and description of all the components and rationale for selection and 
functions 
Intervention Description Basis of rationale  Theory  References  
Secure ePRO 
interface  
Patients can 
report AE from 
home via secure 
integrated 
electronic 
platform  
Patients are happy and able to 
report AE symptoms online (Basch 
et al 2005).  Making data available 
to clinicians in ‘real time’ using 
electronic PRO (ePRO) could have 
the most transformative effect on 
clinical practice by providing 
easily-accessible records to guide 
treatment decisions (Holzner et al 
2015).  
 
The theory of planned behaviour 
(Asjen et al 1991, (Armitage & 
Conner 2001) underpins the 
intervention. Reporting symptoms 
online will be mediated by cognitive 
representations of help seeking 
namely perceived behavioural 
control.   
Ajzen, I. The theory of planned behaviour. Organizational 
Behavior and Human Decision Processes 1991, 50 (2): 
179–211.  
Armitage, C.J. & Conner, M. Efficacy of the theory of 
planned behavior: a meta-analytic review. British Journal 
of Social Psychology 2000, 40: 471–499 
Basch E, Artz D, Dulko D, et al. Patient Online Self-
Reporting of Toxicity Symptoms During Chemotherapy. J 
Clin Oncol 2005, 23:3552-3561. 
Holzner B, Giesinger JM, Zabernigg A, et al. Patients' 
preferences regarding the setting of electronic patient-
reported outcome assessments. Val Health 2015, 18 
(7):A473. 
Linkage of 
ePRO data 
within EPR 
Staff and patients 
can view AE 
reports in tabular 
and graphic 
formats over 
time.  
Using PROs in consultations have 
improved Dr -patient 
communication and QOL, When 
the results are fed back to the 
doctor this has more impact 
(Velikova et al 2004).   
However clinicians need to be 
trained in how to incorporate 
PROs successfully into   
consultations (Santana et al 2015).   
The theoretical approach guiding 
the behavioural change needed 
from staff to access and utilise 
ePROs in consultations was the 
‘diffusions of innovation’ theory 
(Rogers & Everett 1962) and the 
later translational research model 
(Titler 2001). Based on the idea that 
people will eventually adopt a 
system but there will be differences 
in people’s ability to uptake new 
ideas or styles of working.  
 
Rogers, E. M. (1962). Diffusion of innovations (1st 
ed.)1962, New York: Free Press of Glencoe.  
 
Santana MJ, Haverman L, Absolom K, Takeuchi E, Feeny 
D, Grootenhuis M, Velikova G. (2015). Training clinicians 
in how to use patient-reported outcome measures in 
routine clinical practice. Quality of Life Research, 24 
(7):1707-1718. 
 
Titler MG, Everett LQ. Translating research into practice: 
considerations for critical care investigators. Crit Care 
Nurs Clin North Am 2001a;13(4):587-604. 
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Severity 
appropriate   
management 
advice  
Patients receive 
self-management 
for low level AE 
and advice to 
contact the 
hospital for 
severe AE.  
The immediate severity-related 
guidance on how to manage AE is 
a unique feature of our system 
compared to other ePRO web-
portals.  
 
Self-management is becoming an 
increasingly important way for 
patients to manage cancer related 
symptoms during and beyond 
treatment (Boger et al 2015).    
The perceived behavioural control 
element of the TPB would enable 
the prediction of self-management 
intentions with setting of action 
plans and goals. Self-efficacy 
(Bandura 1977; Holman & Lorig 
1992) can translate the behavioural 
intentions into action and 
determine patient competencies in 
management and coping with 
chronic disease.  
Self-efficacy is important for 
managing pain, symptoms, and 
function in patients and is related to 
QOL (Haugland et al 2016) and 
effective self-management can 
result in modest improvements in 
self-efficacy Boger 2015, Gao & 
Yuan 2011) self-efficacy will be 
monitored during the forthcoming 
eRAPID RCT.  
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S2: Specifications of stakeholder requirements from the eRAPID system 
 
Patient  
 User friendly system available to use from computer, tablet, smart phone and ‘in 
house’ hospital kiosks  
 Secure anonymous access via a unique username and password to report 
symptoms and side effects of treatment online   
 Assurance of security and confidentiality when reporting symptoms online  
 Ability to complete the questionnaire at different time points throughout their 
treatment and beyond   
 Can view responses in graphical and tabular format over time and can print and 
email this information 
 An option to have dependencies between questions, to allow skipping irrelevant 
questions or branching  
 Receives tailored on-screen self-management advice for mild symptoms with the 
ability to print and email  
 Hyperlink to more detailed advice available from a dedicated website 
 Immediate advice to call the hospital for severe symptoms  
 
Clinician  
 Can access PRO data in the EPR in real time during the consultation without 
separate login 
 Has easily accessible PRO data in graphical and tabular format (ability to print and 
email this data) 
 Receives an email alert when patients have reported a severe AE 
 Has information about patient symptoms between clinic visits  
  
System administrator/Researcher  
 Easy to follow procedure for setting up new studies and linking participants on QTool 
with their corresponding Electronic Patient Records  
 Can set up multiple questionnaire types with single and multiple response modalities 
 Can assign algorithms corresponding to current treatment guidelines/questionnaire 
scoring and disease group  to provide tailored self management advice and alerts  
 Creates questionnaires by duplicating questions (copy/paste function)   
 Review item responses and graphical and tabular display (can email and print this)   
 Receives high quality PRO data over time with less missing data (patients cannot 
continue if questions are unanswered)  
 Customise questionnaire instructions  
 Access to a downloadable summary of questionnaire responses (by 
study/arm/group) 
 Export real time questionnaire completion data in a standardised format for statistical 
analysis    
 Access to real time daily reports of patients and their responses that triggered alerts 
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S3: Description of the clinical algorithms (A to D) determining level of patient advice. 
 
 
 
 
 
 
 
 
 
 
 
Algorithm D (least severe)
No reported symptoms No advice displayed
Algorithm C
Less than 3 symptoms at Level 
2 and/or a number of 
symptoms at Level 1
Patients receives advise that their symptoms do not require immediate 
medical attention. Patients recieve self-management advice for up to 4 
symptoms, prioritised by medical importance and urgency. 
Algorithm B
Three or more symptoms at 
Level 2. 
Patient recieves advice to contact the hospital when convenient or mention 
these symptom at their next appointment. They recieve self-managment 
advice for all symptoms reported at Level 2.
Algorithm A2
One or more  symptoms at Level 
3 which are NOT a current 
problem
Patient recieves advice to contact the hospital when convenient if they have 
not already done so. They recieve self-management advice for symptoms 
reported at Level 3 and Level 2. 
Algorithm A1 (most severe)
One or more symptoms at 
Level 3 which are reported as a 
current problem.
Patients receive advice to contact the hospital immediately. No other advice 
is displayed. 
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S4: Demographic details of staff (N=19), patient advocates (N=9) and patients (N=13) and who took 
part in iterative rounds of consensus discussion and usability testing. 
  
 
Staff from St James’s Institute of Oncology Leeds (N=19) 
Role  n Cancer speciality and hospital location  
Consultant medical oncologist  4 Gastrointestinal, lung, breast & gynaecology    
Staff grade medical oncologist 1 Chemotherapy pre-assessment  
Lead cancer nurse 1 Institute of oncology 
Nursing sister   1 Chemotherapy day case unit, acute admissions 
unit  
Clinical nurse specialist 4 Breast; gynaecological 
Clinical psychologist  1 Wards and OPD in the institute of oncology  
Dietician 1 Wards and OPD in the institute of oncology 
Physiotherapist 1 Wards and OPD in the institute of oncology 
Staff nurse 1 Chemotherapy pre-assessment (all tumours) 
Macmillan information support   worker 1 Support centre in the institute of oncology 
   
Patient advocates from the patient reported outcomes group (POG) N=9 all had internet access 
Age group n Gender n 
41-50 4 Male  4 
51-60 1 Female  5 
>60 4    
Tumour group  Treatment    
Breast 3 Chemotherapy 5 
Gynaecological 1 Radiotherapy  4 
Gastrointestinal 1 Surgery  5 
Urology 1 Hormone    
Blood/bone 1 Not currently on treatment  1 
Head and Neck 1 Not currently on treatment  
 
1 
Melanoma 1 Not currently on treatment 
 
1 
Patients (N=13) from chemotherapy day case unit all had internet access 
Age n Education  n 
Mean 53 University degree 11 
Range 35-69 Basic school 1 
  Missing 1 
Tumour group    
Breast 2   
Gynaecological 3 Agree to email storage for future contact   
Colorectal 5 Yes 8 
Lung 3 No 1 
Gender   Missing 4 
Male 4   
Female  9   
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S5: Two chemotherapy related treatment AE scenarios designed to test the management algorithms 
for low, moderate and severe symptoms.  
 
Scenario 1 
 Patient 1 is receiving chemotherapy infusions once every 3 weeks. They are suffering from a 
number of symptoms relating to their treatment:  
 Has suffered severe nausea and was not able to eat and drink as usual 
 Has vomited 2 times in the last 24 hours 
 Has had no pain  
 Has had diarrhoea 8 times more a day compared to before treatment 
 Has no  constipation  
 Mouth feels a bit sore 
 Temperature is 37.8  
 Has had chills with shaking but medication has helped  
 Is short of breath when around the house, not able to do some things like household chores 
but only when climbing stairs 
 Is up and about for half of the day. Can wash and dress themselves but cannot do much 
else.  
 Has lacked appetite and has eaten and drank less than usual 
 Has felt tired but this has not been relieved by rest. Had difficulty doing household chores 
and shopping .  
 Occasionally finds it difficult to sleep  
 Has a bit of tingling in fingertips  when handling cold objects 
 Feels quite low in mood and no longer enjoys things they used to, finds it difficult to carry 
out daily activities  
 Occasionally experienced anxiety but this has passed when they have calmed themselves  
 No other side effects to report 
Scenario 2  
 Patient 2 is receiving a weekly chemotherapy infusion. They are suffering from a number of 
symptoms relating to their treatment:  
 Has felt a bit sick but was able to eat and drink as usual 
 Has vomited 4 times in the last 24 hours 
 Has severe pain in abdomen and not able to care for themselves 
 Has had diarrhoea 2 times more a day compared to before treatment 
 Has occasional constipation and sometimes uses laxatives or changes diet 
 Mouth feels very sore and is not able to eat and drink 
 Temperature is 38.1  
 Has not suffered chills and is not shaking 
 Has been short of breath but only when climbing stairs 
 Is up and about almost all of the time. Cannot do heavy work but can do light household 
chores.  
 Has lacked appetite and has been taking supplements 
 Has felt tired but this has been relieved by rest. Able to carry out activities.  
 Has no difficulty sleeping 
 Has tingling in fingertips (problems with buttons on clothes) 
 Feels occasionally low in mood but it passes 
 Quite often feels anxious about prognosis and future treatment and this has interfered with 
daily activities 
 No other side effects  
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S6: Feedback on the system and how usability issues were addressed from staff (N=19) patient 
advocates (N-9) and patients (N=13).  
Patient & staff issues                                                  Resolved by  
 
Patient safety 
Staff 
 When patient gets a red warning (for a severe symptom) 
there should be a contact number of who to ring in clear 
bold font that is easy to see and read  
 Use of the sentence “help your doctors/nurses to 
monitor your symptoms” might suggest that staff are 
actively monitoring each individual and the patient can 
sit back and wait for staff to act.  
 
 The phrase “Please note we cannot provide feedback for 
the other symptoms you have listed”  currently sounds 
like the team behind the system aren’t medically trained. 
  
 When viewing patient feedback from scenario 1 –
(combination of severe symptoms) – temperature was 
not prioritised I suggest the feedback should list all of the 
reasons why the patient should contact the hospital  
 
Logging in to the system   
Patient 
 
 
 A contact telephone number for the 
corresponding oncology team is listed on the 
system in a suitable font size  
 A disclaimer has been inserted  informing 
patients that the information they report in the 
questionnaire will be reported to their medical 
team and can be discussed at their next 
appointment this effect 
 This has been changed to ‘The system cannot 
provide feedback’  
 The algorithm now  prioritises high temperature 
and lists all the severe symptoms why the patient 
should contact the hospital. 
 
 It is too troublesome to reset a forgotten password by 
contacting the research group   
 An email automatic reset function was made available 
 It was not immediately obvious where to go to change 
password  
 This process has been made more intuitive by 
emboldening text and simplifying the procedure 
 The usernames and passwords are difficult to remember 
as they are complex and not full words  
 Developed a different system for generating 
memorable usernames and passwords  
 Might need to add to info on how to log on to press 
(maximise) button to enlarge page  
 The instructions have been amended  
 Not clear how to start the questionnaire - needs to be 
more explicit, e.g.: "Click here to start the questionnaire." 
  
 A large ‘Start’ button has been added beside each 
questionnaire name; clicking the questionnaire will 
also launch the questionnaire. 
Navigating  
Patient  
 
 Difficulty in scrolling down and having to scroll down for 
next button    
 Scrolling function changed to be more obvious and 
scroll bar made larger 
 Needs to be made clear when text can be clicked on and 
expanded 
 A discrete designated  instruction button has been 
installed for these instances 
 Some people may not be able to read the text  Font size has now been increased throughout  
 It would be nice to have a back button in order to 
review/change previous answers, or change an answer 
without using the button on explorer.  
 
Staff 
 There should be an option to ‘pause’ the questionnaire 
and complete later  
 Once logged in it isn’t obvious where a patient should 
click next. A patient will need instructions to use QTool  
 Symptom Report’ in QTool could be called ‘My 
Questionnaire’  
 
 
 
 
 
 Back button now installed  
 
 
 
 This function is now available 
 
 The ‘take the questionnaire button’ has been enlarged 
and patients are now issued with a user manual 
 This is now called ‘my questionnaire’ in the patient 
view   
      
 
21 
 
 
Questionnaire completion, viewing and exporting results 
Patient 
 I have forgotten what I have answered by the end of the 
questionnaire 
 Patients can now view a summary and severity of their 
responses after completion of the questionnaire  
 If you want to amend an answer it is annoying that you 
have to then go through all other answers to get to the 
end again 
 If amending an item, there is a link straight back to the 
review if no questions up to the review point depend 
on the outcome of the amended item 
 Graphical display did not make sense/not useful Didn’t 
understand what I had to click on to get information 
 Installing new interactive software package to display 
graphs (Highcharts)   
 When emailing this was not validated with no warning of 
an invalid email address, lets you submit it anyway  
Staff 
 Basic checks for invalid email and now integrated and 
the system now displays an error message if an invalid 
email is entered  
 There is too much text to read at the end of the 
questions and the patient advice seems hidden  
 When navigating back to view feedback via the  ‘back’ 
button the feedback box did not display the actual 
content just the ‘Your Feedback’ title. The feedback 
printed in a tiny font size which is not acceptable  
 The advice was made more concise and accessible on 
the system 
 This issue is now resolved and the feedback prints in a 
larger font size  
 
 
 
